Topical deep delivery of corticosteroids into the sinonasal cavity improves symptoms and sleep in patients with chronic rhinosinusitis.

Physical variations within the nasal cavity contribute to recurrent bleeding yet often go undetected during standard examinations. Deviated septums represent the most common structural issue ...

The recommended dose of Atzumi is 5.2 mg, the contents of 1 nasal device, administered into 1 nostril. The Food and Drug Administration (FDA) has approved Atzumi ™ (dihydroergotamine ...

ARS Pharma has claimed FDA approval for its epinephrine nasal spray neffy, becoming the first needle-free alternative to EpiPen-style autoinjectors for serious allergic reactions. The green light ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Postnasal drip occurs when mucus from your nasal passages drips down the back of your throat. The symptoms of postnasal drip include coughing and frequent throat clearing, a sore or scratchy throat, ...

A 2D incompressible Navier-Stokes solver for the classic lid-driven cavity problem, implemented with finite difference method, Runge-Kutta time integrator, and projection method for pressure.